Performance of SRPT Sarepta Therapeutics | 5.6% in 12m
Compare SRPT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Sarepta Therapeutics with its related Sector/Index XBI
Performance Duell SRPT vs XBI
| TimeFrame | SRPT | XBI |
|---|---|---|
| 1 Day | -0.21% | 1.16% |
| 1 Week | 2.54% | 7.44% |
| 1 Month | 2.86% | -2.58% |
| 3 Months | 7.72% | 0.42% |
| 6 Months | 68.0% | 29.44% |
| 12 Months | 5.61% | 10.82% |
| YTD | 35.8% | -2.09% |
| Rel. Perf. 1m | 0.70 | |
| Rel. Perf. 3m | 3.01 | |
| Rel. Perf. 6m | 1.09 | |
| Rel. Perf. 12m | -0.21 |
Is Sarepta Therapeutics a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Sarepta Therapeutics (NASDAQ:SRPT) is currently (May 2024)
not a good stock to buy. It has a ValueRay Fundamental Rating of -47.39 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SRPT as of May 2024 is 118.45. This means that SRPT is currently overvalued and has a potential downside of -9.32% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SRPT as of May 2024 is 118.45. This means that SRPT is currently overvalued and has a potential downside of -9.32% (Sold with Premium).
Is SRPT a buy, sell or hold?
- Strong Buy: 11
- Buy: 7
- Hold: 4
- Sell: 0
- Strong Sell: 0
Values above 0%: SRPT is performing better - Values below 0%: SRPT is underperforming
Compare SRPT with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.23% | 5.52% | 49.91% | -19.10% |
| US NASDAQ 100 | QQQ | 1.96% | 6.08% | 50.08% | -28.95% |
| US Dow Jones Industrial 30 | DIA | 2.20% | 5.21% | 53.98% | -10.05% |
| German DAX 40 | DBXD | 2.73% | 5.14% | 50.14% | -7.53% |
| UK FTSE 100 | ISFU | 1.26% | 0.14% | 53.44% | -3.94% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.39% | -0.49% | 63.36% | 15.56% |
| Hongkong Hang Seng | HSI | -4.33% | -3.34% | 67.49% | 20.08% |
| Japan Nikkei 225 | EXX7 | 0.18% | 8.22% | 54.12% | -14.19% |
| India NIFTY 50 | INDA | 1.22% | 0.13% | 47.11% | -23.67% |
| Brasil Bovespa | EWZ | -0.61% | 3.58% | 63.66% | -17.77% |
SRPT Sarepta Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.73% | 6.26% | 48.09% | -30.68% |
| Consumer Discretionary | XLY | 1.17% | 4.59% | 55.70% | -15.91% |
| Consumer Staples | XLP | 2.67% | 2.48% | 56.17% | 4.87% |
| Energy | XLE | 6.75% | 6.88% | 60.40% | -13.33% |
| Financial | XLF | 3.57% | 5.76% | 45.58% | -21.77% |
| Health Care | XLV | 2.14% | 5.43% | 56.29% | -1.23% |
| Industrial | XLI | 2.98% | 4.86% | 45.89% | -18.99% |
| Materials | XLB | 2.92% | 6.87% | 52.52% | -7.84% |
| Real Estate | XLRE | 1.72% | 7.23% | 59.03% | 2.13% |
| Technology | XLK | 2.81% | 7.59% | 51.63% | -27.27% |
| Utilities | XLU | 1.12% | -0.98% | 55.67% | 2.76% |
| Aerospace & Defense | XAR | -0.29% | 1.84% | 52.24% | -15.47% |
| Biotech | XBI | -4.90% | 5.44% | 38.55% | -5.21% |
| Homebuilder | XHB | 1.51% | 6.87% | 30.23% | -42.89% |
| Retail | XRT | 2.15% | 7.79% | 47.04% | -15.40% |
Does Sarepta Therapeutics outperform its market, is SRPT a Sector Leader?
No, over the last 12 months Sarepta Therapeutics (SRPT) made 5.61%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months SRPT made 7.72%, while XBI made 0.42%.
No, over the last 12 months Sarepta Therapeutics (SRPT) made 5.61%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months SRPT made 7.72%, while XBI made 0.42%.
| Period | SRPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.86% | -2.58% | -2.66% |
| 3 Months | 7.72% | 0.42% | 2.48% |
| 12 Months | 5.61% | 10.82% | 24.71% |